Clinical efficacy of nonsurgical treatments for insertional Achilles tendinopathy: a systematic review and network meta-analysis
Refereed conference paper presented and published in conference proceedings
全文
沒有全文檔案提供 |
其它資訊
摘要Introduction: Achilles tendinopathy (AT) is a common overuse injury characterised by pain, swelling, and impaired functional performance. In general medical practice, the incidence of AT is around 2.5 per 1000 patients. In specific active populations, the cumulative lifetime incidence of AT is 50%. The study objective is to evaluate the clinical efficacy of nonsurgical treatments for insertional AT.
Methods: An electronic database search of AMED EBSCOhost, CINAHL EBSCOhost, EMBASE, PEDro, PubMed, Web of Science, and Clinicaltrials.gov was conducted in April 2021. Randomised controlled trials investigating the effects of nonsurgical treatments for insertional AT using the Visual Analog Scale (VAS) as an outcome measure were eligible for inclusion. The primary outcome was the mean change in VAS score at 6 months of follow-up.
Results: A total of four studies with 191 patients met the inclusion criteria and were included. Sample sizes ranged from 15 to 32 per treatment arm (median 48 patients, IQR 33.5-62). Follow-up duration ranged from 2 to 24 weeks (median 24 weeks, IQR 18-24). Five treatment arms were included in the trials, and three of these included extracorporeal shockwave therapy. Four treatment comparisons were made in the network meta-analysis.
Discussion and Conclusion: All studies demonstrated favourable outcomes after short-term treatments for insertional AT. Dietary supplements plus extracorporeal shockwave therapy can induce a better clinical and functional outcome in patients with AT. A standardised questionnaire, Victorian Institute of Sports Assessment (VISA-A) can be used as an outcome measure in future research to allow in-between studies comparison.
Methods: An electronic database search of AMED EBSCOhost, CINAHL EBSCOhost, EMBASE, PEDro, PubMed, Web of Science, and Clinicaltrials.gov was conducted in April 2021. Randomised controlled trials investigating the effects of nonsurgical treatments for insertional AT using the Visual Analog Scale (VAS) as an outcome measure were eligible for inclusion. The primary outcome was the mean change in VAS score at 6 months of follow-up.
Results: A total of four studies with 191 patients met the inclusion criteria and were included. Sample sizes ranged from 15 to 32 per treatment arm (median 48 patients, IQR 33.5-62). Follow-up duration ranged from 2 to 24 weeks (median 24 weeks, IQR 18-24). Five treatment arms were included in the trials, and three of these included extracorporeal shockwave therapy. Four treatment comparisons were made in the network meta-analysis.
Discussion and Conclusion: All studies demonstrated favourable outcomes after short-term treatments for insertional AT. Dietary supplements plus extracorporeal shockwave therapy can induce a better clinical and functional outcome in patients with AT. A standardised questionnaire, Victorian Institute of Sports Assessment (VISA-A) can be used as an outcome measure in future research to allow in-between studies comparison.
著者Violet Man Chi Ko, Mingde Cao, Bruma Sai Chuen Fu, Daniel Tik Pui Fong, Patrick Shu Hang Yung, Samuel Ka Kin Ling
會議名稱The 41st Hong Kong Orthopaedic Association Annual Congress
會議開始日06.11.2021
會議完結日07.11.2021
會議地點Hong Kong
會議國家/地區香港
出版年份2021
月份11
出版社Hong Kong Academy of Medicine Press
出版地Hong Kong
語言美式英語
